These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23144745)

  • 1. Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.
    Martinelli N; Traglia M; Campostrini N; Biino G; Corbella M; Sala C; Busti F; Masciullo C; Manna D; Previtali S; Castagna A; Pistis G; Olivieri O; Toniolo D; Camaschella C; Girelli D
    PLoS One; 2012; 7(10):e48250. PubMed ID: 23144745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.
    Yegin ZA; İyidir ÖT; Demirtaş C; Suyanı E; Yetkin İ; Paşaoğlu H; İlhan Ç; Sucak GT
    J Endocrinol Invest; 2015 Mar; 38(3):333-8. PubMed ID: 25245337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
    Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
    An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin resistance in dysmetabolic iron overload.
    Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
    Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study.
    Galesloot TE; Geurts-Moespot AJ; den Heijer M; Sweep FC; Fleming RE; Kiemeney LA; Vermeulen SH; Swinkels DW
    J Med Genet; 2013 Sep; 50(9):593-8. PubMed ID: 23794717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
    Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
    Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.
    Traglia M; Girelli D; Biino G; Campostrini N; Corbella M; Sala C; Masciullo C; Viganò F; Buetti I; Pistis G; Cocca M; Camaschella C; Toniolo D
    J Med Genet; 2011 Sep; 48(9):629-34. PubMed ID: 21785125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE; Brunt EM; Kowdley KV;
    Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
    Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
    Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome.
    Trombini P; Paolini V; Pelucchi S; Mariani R; Nemeth E; Ganz T; Piperno A
    Liver Int; 2011 Aug; 31(7):994-1000. PubMed ID: 21733088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
    Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E
    Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
    Rametta R; Fracanzani AL; Fargion S; Dongiovanni P
    Curr Pharm Des; 2020; 26(10):1025-1035. PubMed ID: 32003680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist.
    van Deuren M; Kroot JJ; Swinkels DW
    Haematologica; 2009 Sep; 94(9):1297-300. PubMed ID: 19608676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
    J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.